Parkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1

Parkinson’s disease (PD) is a debilitating movement disorder characterised by the loss of dopaminergic neurons in the substantia nigra. As neuroprotective agents mitigating the rate of neurodegeneration are unavailable, the current therapies largely focus only on symptomatic relief. Here, we identif...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jolene Su Yi, Lee, Bernett, Lim, Jackwee, Ma, Dong Rui, Goh, Jia Xin, Goh, Suh Yee, Gulam, Muhammad Yaaseen, Koh, Ser Mei, Lee, Weiling Wendy, Feng, Lei, Wang, Qing, Chao, Yinxia, Rötzschke, Olaf, Tan, Eng King
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139896/
https://www.ncbi.nlm.nih.gov/pubmed/35626686
http://dx.doi.org/10.3390/cells11101649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139896/
https://www.ncbi.nlm.nih.gov/pubmed/35626686
http://dx.doi.org/10.3390/cells11101649

Ejemplares similares